Following a dialogue with pharmaceutical companies that took place in the previous months, the Italian Medicines Agency (AIFA) has adopted decision no. 1313/2020.

Such decision has been published on the Agency’s institutional website and concerns the shares of the pharmaceutical expenditure payback for direct purchases in 2019, allocated to each pharmaceutical company holding a marketing authorisation.

The shares are broken down by region and autonomous province according to the per capita criterion, pursuant to article 1, paragraph 580, of Law no. 145/18.

Published on: 11 December 2020
Last updated on: 16 December 2020